Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTI-TREX: Bayesian Dose-adjustment of Enoxaparin in Pediatric Kidney Transplant Recipients
NCT05672550Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2023
- Primary completion
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in Graft Thrombosis, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2023; status: completed.
02
Drugs
enoxaparin
03
Conditions
Graft Thrombosis
Beyond the preview
Go deeper on NCT05672550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672550.